Warfarin Use in Nursing Home Residents: Results from the 2004 National Nursing Home Survey Parinaz K. Ghaswalla, PhD, Spencer E. Harpe, PharmD, PhD, MPH, Patricia W. Slattum, PharmD, PhD American Journal of Geriatric Pharmacotherapy Volume 10, Issue 1, Pages 25-36.e2 (February 2012) DOI: 10.1016/j.amjopharm.2011.12.001 Copyright © 2012 Elsevier HS Journals, Inc. Terms and Conditions
Figure 1 Summary of use of warfarin and other antiplatelet medications in eligible nursing home (NH) residents with atrial fibrillation (AF). American Journal of Geriatric Pharmacotherapy 2012 10, 25-36.e2DOI: (10.1016/j.amjopharm.2011.12.001) Copyright © 2012 Elsevier HS Journals, Inc. Terms and Conditions
Figure 2 Use of warfarin and other antiplatelet medications by nursing home residents with atrial fibrillation (n = 1767). *Combination therapy includes (1) warfarin and aspirin (n = 17), (2) aspirin and clopidogrel (n = 20), and (3) warfarin and clopidogrel (n = 4). American Journal of Geriatric Pharmacotherapy 2012 10, 25-36.e2DOI: (10.1016/j.amjopharm.2011.12.001) Copyright © 2012 Elsevier HS Journals, Inc. Terms and Conditions